检索

期
标题
作者
卷 2, 编号 1 (2005)
Kogda neobkhodimo nachinat' lechenie arterial'noy gipertonii s fiksirovannykh kombinatsiy? Novye tendentsii
Ostroumova O., Golovina O.
卷 10, 编号 4 (2013)
Rational pharmacotherapy of hypertension. Urapidil potential
Morozova T., Andruschishina T., Shmarova D.
卷 1, 编号 1 (2004)
Sravnitel'naya otsenka antigipertenzivnoy effektivnosti lozartana i ego fiksirovannoy kombinatsii s gidrokhlortiazidom pri 24-nedel'noy terapii u bol'nykh gipertonicheskoy bolezn'yu
Ratova L., Tolpygina S., Chazova I.
卷 16, 编号 3 (2019)
The possibilities of angiotensin receptor blocker azilsartan medoxomil and its combination with chlortalidone in cardiovascular risk decrease in patients with obesity, metabolic syndrome and diabetes mellitus
Zhernakova J., Chazova I., Blinova N.
PDF
(Rus)
卷 15, 编号 3 (2018)
Guidelines for diagnostics and treatment of hypertension 2018 - European experts’opinion [Guidelines]
Chazova I., Zhernakova Y.
PDF
(Rus)
卷 14, 编号 1 (2017)
Fixed combination of highly selective β-adrenoblocker bisoprolol and calcium antagonist amlodipine (Concor® AM) for arterial hypertension treatment in metabolic disorder patients
Zhernakova Y., Martyniuk T., Arkhipova O., Azimova M., Rogoza A., Chazova I.
PDF
(Rus)
卷 6, 编号 3 (2009)
The combination therapy: when efficiency and safety go an arm about arm
Chazova I., Ratova L.
卷 13, 编号 3 (2016)
Combined pharmacotherapy of arterial hypertension. Overview fixed combination antihypertensive drugs
Morozova T., Andrushchishina T., Yudina I.
PDF
(Rus)
卷 11, 编号 1 (2014)
Practical aspects of fixed combinations in the treatment of hypertension
Ogarkov M., Baranova M., Skripchenko A.
PDF
(Rus)
卷 15, 编号 4 (2018)
Combined antihypertensive therapy in the light of modern recommendations: strategy of one tablet
Morozova T.
PDF
(Rus)
卷 13, 编号 2 (2016)
Diuretics in combination antihypertensive therapy: focus on forecast
Chazova I., Martyniuk T.
PDF
(Rus)
卷 1, 编号 2 (2004)
Kombinirovannaya terapiya arterial'noy gipertenzii s pozitsiy profilaktiki serdechno-sosudistykh oslozhneniy i patogeneza
Boytsov S.
卷 15, 编号 4 (2018)
Features of antihypertensive and vasoprotective efficiency of combination of valsartan and amlodipine in patients with obesity under different polymorphic variants of CYP2C9 and CYP11B2 genes
Kovalenko F., Skibitsky V., Fendrikova A.
PDF
(Rus)
卷 12, 编号 3 (2015)
Fixed dose combinations for the treatment arterial hypertension: the real way to improve control
Morozova T., Andreev S.
PDF
(Rus)
卷 10, 编号 3 (2013)
Korrektsiya dislipidemiy pri soputstvuyushchey arterial'noy gipertonii s pozitsiy obnovlennoy paradigmy serdechno-sosudistogo riska
Gurevich V.
卷 12, 编号 1 (2015)
Patients with arterial hypertension associated with metabolic disorders: characteristics and therapeutic approach
Zhernakova Y., Sharipova G., Chazova I.
PDF
(Rus)
卷 9, 编号 4 (2012)
Diurnal blood pressure variability as a risk factor for complications of arterial hypertension
Ostroumova O., Reznikova K.
卷 1, 编号 1 (2004)
Kombinirovannaya terapiya arterial'noy gipertenzii
Chazova I., Ratova L.
卷 12, 编号 2 (2015)
The first results of an international clinical trial VICTORY:the efficacy and safety of antihypertensive valsartan monotherapy and the fixed combination of valsartan and hydrochlorothiazide usingdifferent dosage regimens in patients with 1-2 degree arterial hypertension
Chazova E., Martyniuk T.
PDF
(Rus)
卷 6, 编号 2 (2009)
The intensive control of blood pressure: possibilities of the combined therapy.
Andrushchishina T., Morozova T.
卷 16, 编号 4 (2019)
Role of fixed combinations in modern treatment of arterial hypertension: new or well overlooked old?
Adasheva T., Samorukova E., Zadionchenko V., Laricheva K.
PDF
(Rus)
卷 14, 编号 2 (2017)
The results of the international clinical study VICTORY: efficacy and safety of antihypertensive monotherapy with valsartan (Valsacor®) and its fixed combination with hydrochlorothiazide (Valsacor® H) in routine clinical practice in patients with grade 1 and grade 2 hypertension
Chazova I., Martynyuk T., Accetto R., Sirenko Y., Vincelj J., JWidimsky J., Barbič-Žagar B., Arhipov M., Grinshtein Y., Ostroumova O., Galjavich A., Rotar' O., Haisheva L., Nedogoda S.
PDF
(Rus)
卷 12, 编号 2 (2015)
Clinical case: combination therapy with iloprost and sildenafil in the treatment of idiopathic pulmonary hypertension
Zavyrylina I., Arkhipova O., Saidova M., Danylov N., Martynyuk T., Chazova I.
PDF
(Rus)
卷 3, 编号 2 (2006)
Kombinirovannaya terapiya ingibitorom angiotenzinprevrashchayushchego fermenta i diuretikom
Chazova I., Martynyuk T.
卷 6, 编号 1 (2009)
Clinical case: Effectiveness of combined therapyOrlistat and Irbesartan at the Metabolic syndrome patient with Arterial hypertension
Ivanov K., Mychka V., Kirillova M., Chazova I., Ivanov K., Mychka V., Kirillov M., Chazova I.
卷 14, 编号 2 (2017)
A new fixed combination of perindopril, indapamide and amlodipine. "Three in one" is the way to improve the results of arterial hypertension treatment
Temnikova E.
PDF
(Rus)
卷 11, 编号 1 (2014)
Experience of treating hypertension in an outpatient setting: a clinical case
Agafonov A., Khozyainova N., Petruschenkova O.
PDF
(Rus)
卷 3, 编号 2 (2006)
Pri vsem bogatstve vybora drugoy al'ternativy net Issledovanie ETNA Plyus (ETNA v zhizni vracha polikliniki)
Chazova I., Ratova L.
卷 6, 编号 1 (2009)
Possible combinations of antihypertensive drugs at treatment of arterial hypertension at patientswith metabolic syndrome
Mychka V., Chazova I., Mychka V., Chazova I.
卷 11, 编号 1 (2014)
Rational therapy of hypertension with concomitant ischemic heart disease
Chukaeva I., Orlova N., Soloveva M.
PDF
(Rus)
卷 2, 编号 2 (2005)
Korotkiy put' k zavetnoy tseli – ko-renitek dlya patsienta s AG
Chazova I., Ratova L.
1 - 31 的 31 信息

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回（例如，隐含AND）
  • 使用OR结合多个检索词，便于查找含有这些检索词的文章，例如education OR research
  • 使用括号来创建更复杂的查询; 例如：archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如： "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如：online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语